Crabbe3: sample sizes

Number of animals tested for each measure in this project, by strain and sex.       Cells with N < 5 are colored pink.


More info about these strains
Crabbe3 measure Sex 129S1/SvImJ A/J AKR/J B6D2F1/J BALB/cByJ BTBR T<+> Itpr3<tf>/J C3H/HeJ C57BL/6J C57L/J C58/J CAST/EiJ DBA/2J FVB/NJ MOLF/EiJ NOD/ShiLtJ NZB/BlNJ PERA/EiJ PL/J SJL/J SM/J SPRET/EiJ SWR/J
bw   body weight on test day (local parameter)   15801 Female 19 18 12 19 15 19 19 19 19
Male 19 19 12 17 11 19 19 19 19
FS_3rpm_EtOH_1   latency to fall, fixed speed 3 rpm rotarod , dose: 1 g/kg i.p.   15810 Female 4 3 4 4 2 4 4 4 4
Male 3 3 4 4 2 4 4 4 4
FS_3rpm_EtOH_2   latency to fall, fixed speed 3 rpm rotarod , dose: 2 g/kg i.p.   15811 Female 4 2 4 4 4 4 4 4 4
Male 4 4 4 4 4 4 4 4
FS_3rpm_EtOH_3   latency to fall, fixed speed 3 rpm rotarod , dose: 3 g/kg i.p.   15812 Female 4 4 4 4 3 4 4 4 3
Male 3 3 4 4 2 4 4 4 4
FS_6rpm_EtOH_1   latency to fall, fixed speed 6 rpm rotarod , dose: 1 g/kg i.p.   15815 Female 4 1 3 4 3 4 4 1 4
Male 1 1 4 4 2 4 4 3 4
FS_6rpm_EtOH_2   latency to fall, fixed speed 6 rpm rotarod , dose: 2 g/kg i.p.   15816 Female 4 4 4 3 2 4 2 4
Male 4 4 4 4 4 2 4
FS_6rpm_EtOH_3   latency to fall, fixed speed 6 rpm rotarod , dose: 3 g/kg i.p.   15817 Female 4 3 4 3 3 4 4 4 4
Male 4 2 4 4 2 4 4 2 4
FS_10rpm_EtOH_1   latency to fall, fixed speed 10 rpm rotarod , dose: 1 g/kg i.p.   15820 Female 3 3 3 3 4 3 3
Male 3 3 1 2 4 2 3
FS_10rpm_EtOH_2   latency to fall, fixed speed 10 rpm rotarod , dose: 2 g/kg i.p.   15821 Female 4 2 4 3 4 4 1 3
Male 4 2 2 2 3 2 3
FS_10rpm_EtOH_3   latency to fall, fixed speed 10 rpm rotarod , dose: 3 g/kg i.p.   15822 Female 4 1 2 3 2 3 2 4
Male 4 1 2 2 1 2 3 2
ARR1_performance   accelerating rotarod (ARR1) acquisition trial average over all trials (20 rpm/min)   15830 Female 6 6 6 4 6 6 6 6
Male 6 6 4 3 6 6 6 6
ARR1_improvement   accelerating rotarod (ARR1) acquisition trial average of last 3 trials minus average of first 3 trials (20 rpm/min)   15831 Female 6 6 6 4 6 6 6 6
Male 6 6 4 3 6 6 6 6
ARR1_pre_20rpm   latency to-fall, accelerating rotarod, test day 1 20 rpm/min (ARR1) , baseline   15840 Female 7 7 7 5 6 7 7 7
Male 7 7 5 4 7 7 7 7
ARR1_post_20rpm   latency to-fall, accelerating rotarod, test day 1 20 rpm/min (ARR1) , ethanol   15841 Female 6 6 6 5 6 6 6 6
Male 6 6 4 2 6 4 6 6
ARR1_chg_20rpm   latency to-fall, accelerating rotarod, test day 1 20 rpm/min (ARR1) , difference   15842 Female 6 6 6 5 6 6 6 6
Male 6 6 4 2 6 4 6 6
ARR1_pre_30rpm   latency to-fall, accelerating rotarod, test day 2 30 rpm/min (ARR1) , baseline   15845 Female 7 7 7 5 7 7 6 7
Male 7 7 5 3 7 7 7 7
ARR1_post_30rpm   latency to-fall, accelerating rotarod, test day 2 30 rpm/min (ARR1) , ethanol   15846 Female 5 5 5 3 5 5 4 5
Male 5 5 3 2 5 5 5 5
ARR1_chg_30rpm   latency to-fall, accelerating rotarod, test day 2 30 rpm/min (ARR1) , difference   15847 Female 5 5 5 3 5 5 4 5
Male 5 5 3 2 5 5 5 5
ARR2_performance   accelerating rotarod (ARR2) acquisition trial average over all trials (20 rpm/min)   15850 Female 10 8 10 10 12 10 8 10 10 10 10 10 8 12 6 10 12 8 14 5 10
Male 10 10 8 10 6 8 10 8 10 9 8 11 7 12 12 12 8 12 10 2 10
ARR2_improvement   accelerating rotarod (ARR2) acquisition trial average of first 2 trials minus average of last 2 trials (20 rpm/min)   15851 Female 10 8 10 10 11 10 8 10 10 8 10 10 8
Male 10 10 8 10 6 8 10 8 10 8 8 11
ARR2_pre_20rpm   latency to fall, accelerating rotarod, 20 rpm/min (ARR2) , baseline   15855 Female 10 8 10 10 12 10 8 10 10 8 10 10 8 12 6 10 12 8 14 3 10
Male 10 10 8 10 6 8 10 8 10 8 8 11 7 12 12 12 8 12 10 2 10
ARR2_post_20rpm   latency to fall, accelerating rotarod, 20 rpm/min (ARR2) , ethanol   15856 Female 10 8 9 10 12 10 8 10 10 5 10 10 8 12 6 10 12 8 14 3 10
Male 10 10 8 10 6 8 10 8 10 8 8 11 6 12 12 12 8 12 10 2 10
ARR2_chg_20rpm   average latency to fall, accelerating rotarod, 20 rpm/min (ARR2), post-injection trials minus pre-injection trials (ETPOST - ETBASE)   15857 Female 10 8 9 10 12 10 8 10 10 5 10 10 8 12 6 10 12 8 14 3 10
Male 10 10 8 10 6 8 10 8 10 8 8 11 6 12 12 12 8 12 10 2 10
ARR2_chg_20rpm_saline   average latency to fall, accelerating rotarod, 20 rpm/min (ARR2), post-injection saline control minus pre-injection saline control (SALPOST - SALBASE)   15858 Female 10 8 10 10 12 10 8 10 10 8 10 10 8 12 6 9 12 8 14 3 10
Male 10 10 8 10 6 8 10 8 10 8 8 11 7 12 12 12 8 12 10 2 9